盐酸曲美他嗪对老年心衰患者血浆脑钠肽及6
时间:2019-3-3来源:日常保健 作者:佚名 点击:次
本实验观察曲美他嗪对慢性充血性心力衰竭(CHF)患者心功能的影响。
Toobserveinfluenceoftrimetazidineoncardiacfunctioninpatientswithchronicheartfailure(CHF).70例符合入选标准的CHF患者按数字表法被随机均分为曲美他嗪组和常规治疗组,各35例。常规治疗组根据病情给予洋地黄、利尿剂、血管紧张素转化酶抑制剂等治疗,曲美他嗪组在常规治疗组基础上加用曲美他嗪,疗程4周,分别于治疗前后检测患者血浆脑钠肽(BNP)水平,并对患者进行6min步行试验(6MWT)。
Accordingtonumbertablemethod,atotalof70CHFpatientsaccordedwithinclusionstandardswererandomlyandequallydividedintotrimetazidinegroupandroutinetreatmentgroup.Accordingtopatient′scondition,routinetreatmentgroupreceiveddigitalis,diuretics,angiotensinconvertingenzymeinhibitorsetcCHFroutinefreatment.Trimetazidinegroupadditionallyreceivedtrimetazidinebasedonroutinetreatment.Thetreatmentperiodwasfourweeks.Plasmabrainnatriureticpeptide(BNP)levelwasmeasuredandpatientsreceived6minwalkingtest(6MWT)beforeandaftertreatment.两组患者治疗后血浆BNP水平均较治疗前明显降低(P0.01),且曲美他嗪组降低幅度较常规治疗组降低更显著[(.60±.22)pg/ml比(.89±.61)pg/ml,P0.05];两组患者治疗后6min步行距离均较治疗前显著增加(P0.01),且曲美他嗪组增加幅度较常规治疗组更显著[(.06±65.18)m比(.46±51.16)m,P0.01]。
Comparedwithbeforetreatment,therewassignificantdecreaseinplasmaBNPlevelintwogroupsaftertreatment(P0.01),治疗白癜风药物拉萨治疗白癜风的医院- 上一篇文章: 听懂心衰的5个求救信号
- 下一篇文章: 没有了